FDA Device Registration & Listing · Lodi, CA, US · Registration 3016838963
Normalized identity and public registration information from FDA records.
| Product Code | Device Name | Medical Specialty | Device Class | Regulation Number | Created Date |
|---|---|---|---|---|---|
| NPR | Test, Factor Ii G20210a Mutations, Genomic Dna Pcr | Hematology | Class 2 | 864.7280 | 2025-05-21 |
| NPQ | Test, Factor V Leiden Mutations, Genomic Dna Pcr | Hematology | Class 2 | 864.7280 | 2025-05-21 |
| OUY | Trichomonas Vaginalis Nucleic Acid Amplification Test System | Immunology | Class 2 | 866.3860 | 2024-12-11 |
| JSM | Culture Media, Non-Propagating Transport | Microbiology | Class 1 | 866.2390 | 2024-12-11 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2024-12-11 |
| QVR | Multiplex Nucleic Acid Detection System For Biothreat Agents | Immunology | Class 2 | 866.4000 | 2026-05-27 |
| NJR | Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test | Microbiology | Class 1 | 866.3740 | 2022-06-08 |
| QDC | Dna-Based Test For Minimal Residual Disease For Hematologic Malignancies | Pathology | Class 2 | 866.6100 | 2024-12-11 |
| PGX | Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System | Microbiology | Class 2 | 866.2680 | 2017-09-26 |
| NSU | Instrumentation For Clinical Multiplex Test Systems | Clinical Chemistry | Class 2 | 862.2570 | 2022-04-08 |
| PQA | Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System | Microbiology | Class 2 | 866.3975 | 2022-04-08 |
| NJR | Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test | Microbiology | Class 1 | 866.3740 | 2004-04-13 |
| OCC | Respiratory Virus Panel Nucleic Acid Assay System | Microbiology | Class 2 | 866.3980 | 2017-02-15 |
| JSM | Culture Media, Non-Propagating Transport | Microbiology | Class 1 | 866.2390 | 2017-02-15 |
| SBP | Simple Point-Of-Care Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Test | Microbiology | Class 2 | 866.3171 | 2024-07-02 |
| NQX | System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2024-12-11 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2024-12-11 |
| QJR | Reagents, 2019-Novel Coronavirus Nucleic Acid | Unknown | Class N | N/A | 2020-11-16 |
| QQX | Respiratory Specimen Nucleic Acid Sars-Cov-2 Test | Microbiology | Class 2 | 866.3981 | 2023-11-10 |
| QOF | Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents | Microbiology | Class 2 | 866.3981 | 2025-05-21 |
| OHQ | Multi-Analyte Controls Unassayed | Clinical Chemistry | Class 1 | 862.1660 | 2024-12-18 |
| JSM | Culture Media, Non-Propagating Transport | Microbiology | Class 1 | 866.2390 | 2020-06-09 |
| OCC | Respiratory Virus Panel Nucleic Acid Assay System | Microbiology | Class 2 | 866.3980 | 2020-06-09 |
| NQX | System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2013-11-13 |
| MMW | System, Test, Tumor Marker, Monitoring, Bladder | Immunology | Class 2 | 866.6010 | 2020-12-04 |
| QOF | Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents | Microbiology | Class 2 | 866.3981 | 2025-02-11 |
| QQX | Respiratory Specimen Nucleic Acid Sars-Cov-2 Test | Microbiology | Class 2 | 866.3981 | 2025-02-20 |
| NJR | Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test | Microbiology | Class 1 | 866.3740 | 2023-11-02 |
| PQA | Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System | Microbiology | Class 2 | 866.3975 | 2022-08-17 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2022-08-17 |
| POC | System, Nucleic Acid Amplification Test, Dna, Antimicrobial Resistance Marker, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2020-12-04 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2024-12-11 |
| NQX | System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2024-12-11 |
| NPR | Test, Factor Ii G20210a Mutations, Genomic Dna Pcr | Hematology | Class 2 | 864.7280 | 2023-04-05 |
| NPQ | Test, Factor V Leiden Mutations, Genomic Dna Pcr | Hematology | Class 2 | 864.7280 | 2023-04-05 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2023-04-05 |
| QTP | Reagents, Monkeypox Virus Nucleic Acid. | Unknown | Class N | N/A | 2023-02-13 |
| NIJ | System, Test, Genotypic Detection, Resistant Markers, Enterococcus Species | Microbiology | Class 2 | 866.1640 | 2010-12-14 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2010-12-14 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2012-12-07 |
| NJR | Nucleic Acid Amplification Assay System, Group B Streptococcus, Direct Specimen Test | Microbiology | Class 1 | 866.3740 | 2012-12-07 |
| NQX | System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2008-10-17 |
| OHQ | Multi-Analyte Controls Unassayed | Clinical Chemistry | Class 1 | 862.1660 | 2012-12-11 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2024-12-11 |
| POC | System, Nucleic Acid Amplification Test, Dna, Antimicrobial Resistance Marker, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2024-12-11 |
| NIA | Assay, Direct, Nucleic Acid Amplification, Influenza Virus | Microbiology | Class 1 | 866.3330 | 2020-03-04 |
| OCC | Respiratory Virus Panel Nucleic Acid Assay System | Microbiology | Class 2 | 866.3980 | 2017-02-15 |
| OMN | C. Difficile Nucleic Acid Amplification Test Assay | Microbiology | Class 1 | 866.2660 | 2011-12-01 |
| NQX | System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2006-04-25 |
| OYX | Bcr/Abl1 Monitoring Test | Medical Genetics | Class 2 | 866.6060 | 2019-10-10 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2019-10-10 |
| QOF | Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents | Microbiology | Class 2 | 866.3981 | 2023-08-18 |
| PEU | System, Nucleic Acid-Based, Mycobacterium Tuberculosis Complex, Resistance Marker, Direct Specimen | Microbiology | Class 2 | 866.3373 | 2024-12-11 |
| QOF | Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents | Microbiology | Class 2 | 866.3981 | 2025-05-21 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2018-01-16 |
| PMY | System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-Susceptible Gram Negative Organism, Colony | Microbiology | Class 2 | 866.1640 | 2018-01-16 |
| POC | System, Nucleic Acid Amplification Test, Dna, Antimicrobial Resistance Marker, Direct Specimen | Microbiology | Class 2 | 866.1640 | 2018-01-16 |
| LLH | Reagents, Clostridium Difficile Toxin | Microbiology | Class 1 | 866.2660 | 2009-11-20 |
| OOI | Real Time Nucleic Acid Amplification System | Clinical Chemistry | Class 2 | 862.2570 | 2022-09-09 |
| PGX | Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System | Microbiology | Class 2 | 866.2680 | 2022-09-09 |
No US Agent registered (Local establishment).
| Registration Number | Establishment Name | Location |
|---|---|---|
| 3004530258 | CEPHEID | Sunnyvale, CA, US |
| 3009613136 | CEPHEID AB | SOLNA Stockholm, SE |
| 510(k) Number | Applicant | Device Name | Decision Date |
|---|---|---|---|
| K914894 | Microtest | VIRAPURE, CHLAMYPURE AND MYCOPURE | 1991-12-18 |
| Recall ID | Recalling Firm | Recall Class | Product Description |
|---|---|---|---|
| Z-0028-2018 | Cepheid | N/A | Xpert EV Assay, Catalog GXEV-100N-10.
The Cepheid Xpert EV assay is a reverse transcription polymerase chain reaction (RT-PCR) using the GeneXpert Dx System for the presumptive qualitative detection of enterovirus (EV) RNA in cerebrospinal fluid (CSF) specimens from individuals with signs and symptoms of meningitis. |
| Z-0027-2018 | Hologic, Inc | 2 | Panther(R) System, Catalog Number 902615, For Use with Hologic Assays, For In Vitro Diagnostic Use |
| Z-0042-2025 | Luminex Molecular Diagnostics Inc | 2 | NxTAG Respiratory Pathogen Panel, REF: I051C0447 |
| Z-0004-2022 | Abbott Molecular, Inc. | N | Alinity m SARS-CoV-2 Amp Kit (Emergency Use Authorization, US Assay) and Alinity m SARS-CoV-2 Application Specification File. in vitro diagnostic |
| Z-0005-2022 | Abbott Molecular, Inc. | N | Alinity m Resp-4-Plex AMP Kit (Emergency Use Authorization, US Assay) and Alinity m Resp-4-Plex Application Specification File. in vitro diagnostic |
| Registration Number | Establishment Name | Location |
|---|---|---|
| 3004530258 | CEPHEID | Sunnyvale, CA, US |
| 2243471 | ROCHE MOLECULAR SYSTEMS, INC. | Branchburg, NJ, US |
| 2024800 | Hologic, Inc. | SAN DIEGO, CA, US |
| 3007420875 | GeneOhm Sciences Canada, ULC. | Quebec, CA |
| 3019837962 | Abbott Molecular Distribution Center | Itasca, IL, US |
3016838963 when referencing this establishment in official correspondence.